Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease

Inclusion Criteria:

- Diagnosis of dementia of the Alzheimer's type

- Males, and females who are surgically sterile or one year postmenopausal

- A primary caregiver willing to accept responsibility for supervising the treatment

Exclusion Criteria:

- Any condition (other than Alzheimer's) that could explain patient's dementia

- An advanced, severe or unstable disease that may put the patient at special risk

- Current diagnosis of active, uncontrolled seizure disorder or unstable cardiovascular
disease